China urgently approves the first drug to treat Covid-19

On December 9, the regulator approved the monoclonal antibody therapy for the treatment of Covid-19, developed by Tsinghua University, Shenzhen 3 People’s Hospital and Brii Biosciences. A monoclonal antibody is a protein that attaches to the mutant protein of nCoV, reducing the ability of the virus to invade body cells. The newly approved drug contains […]